Literature DB >> 8046351

Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH.

R G Urban1, R M Chicz, J L Strominger.   

Abstract

The predominant peptides bound to major histocompatibility complex class II molecules expressed on human B cells are derived from a relatively limited number of self proteins. To determine whether any of the prebound self peptides might be released in endosomes during recycling, water-soluble HLA-DR1 molecules were incubated with a high affinity synthetic peptide at pH 4.0 and 7.0 at 37 degrees C. The resulting bound peptide repertoire was then acid extracted, and separated by reversed-phase high performance liquid chromatography. Using a combination of mass spectrometry and ultraviolet spectroscopy, prebound self peptides and newly bound synthetic peptide were characterized. Most self peptides bound to HLA-DR1 were not appreciably released during extended exposure to pH 4.0. However, some invariant chain-derived peptides were uniquely released at this pH.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046351      PMCID: PMC2191616          DOI: 10.1084/jem.180.2.751

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Irreversible association of peptides with class II MHC molecules in living cells.

Authors:  A Lanzavecchia; P A Reid; C Watts
Journal:  Nature       Date:  1992-05-21       Impact factor: 49.962

2.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.

Authors:  J M Riberdy; J R Newcomb; M J Surman; J A Barbosa; P Cresswell
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

3.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant.

Authors:  A Sette; S Ceman; R T Kubo; K Sakaguchi; E Appella; D F Hunt; T A Davis; H Michel; J Shabanowitz; R Rudersdorf
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

4.  pH dependence of the interaction between immunogenic peptides and MHC class II molecules. Evidence for an acidic intracellular compartment being the organelle of interaction.

Authors:  S Mouritsen; A S Hansen; B L Petersen; S Buus
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

5.  Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line.

Authors:  J C Gorga; V Horejsí; D R Johnson; R Raghupathy; J L Strominger
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

Review 6.  Acidification of the endocytic and exocytic pathways.

Authors:  I Mellman; R Fuchs; A Helenius
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

7.  Enhancement of peptide antigen presentation by a second peptide.

Authors:  A I de Kroon; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

8.  pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule.

Authors:  P A Reay; D A Wettstein; M M Davis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

9.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

10.  Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal.

Authors:  M S Anderson; K Swier; L Arneson; J Miller
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  15 in total

1.  Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.

Authors:  A B Vogt; H Kropshofer; G Moldenhauer; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 2.  Selection of the MHC class II-associated peptide repertoire by HLA-DM.

Authors:  S O Arndt; A B Vogt; G J Hämmerling; H Kropshofer
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

3.  A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.

Authors:  H Kropshofer; A B Vogt; C Thery; E A Armandola; B C Li; G Moldenhauer; S Amigorena; G J Hämmerling
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

4.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

5.  Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding.

Authors:  H Kropshofer; A B Vogt; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

6.  Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes.

Authors:  O Rötzschke; K Falk; J Mack; J M Lau; G Jung; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

8.  Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis.

Authors:  Andreas Hermansson; Daniel F J Ketelhuth; Daniela Strodthoff; Marion Wurm; Emil M Hansson; Antonino Nicoletti; Gabrielle Paulsson-Berne; Göran K Hansson
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

9.  A structural transition in class II major histocompatibility complex proteins at mildly acidic pH.

Authors:  H A Runnels; J C Moore; P E Jensen
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

10.  Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein.

Authors:  G Zhong; P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.